Mira Pharmaceuticals (MIRA) Other Accumulated Expenses (2022 - 2025)

Mira Pharmaceuticals (MIRA) posted Other Accumulated Expenses of $572865.0 for Q4 2025, up 3825.88% sequentially from $14592.0 in Q3 2023.

Mira Pharmaceuticals (MIRA) Other Accumulated Expenses (2022 - 2025) Analysis & Trends

Mira Pharmaceuticals (MIRA) has 3 years of Other Accumulated Expenses data on file, last reported at $572865.0 in Q4 2025.

  • Quarterly Other Accumulated Expenses changed N/A year-over-year to $572865.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $572865.0 (changed N/A YoY) and the FY2025 annual result came in at $572865.0, changed N/A from the prior year.
  • Other Accumulated Expenses improved to $572865.0 in Q4 2025 per MIRA's latest filing, from $14592.0 in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $572865.0 in Q4 2025, with the low at $14592.0 in Q3 2023.
  • Average Other Accumulated Expenses over 3 years is $203330.3, with a median of $22534.0 recorded in 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Mira Pharmaceuticals 22.51 Mn 11.48 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 572,865.00
Sep 30, 2023 14,592.00
Dec 31, 2022 22,534.00